Patent ID: 8017122

Claim:
A method of reducing inflammation in a mammal with a skin or epidermal condition having increased infiltration of cutaneous lymphocyte antigen (CLA+) T cells comprising administering to the mammal a monoclonal antibody or antibody fragment thereof, wherein the monoclonal antibody is produced by the hybridoma deposited with the American Type Culture Collection having the ATCC Patent Deposit Designation selected from the group consisting of: a) ATCC Patent Deposit Designation PTA-6815; b) ATCC Patent Deposit Designation PTA-6816; c) ATCC Patent Deposit Designation PTA-6829; d) ATCC Patent Deposit Designation PTA-6830; e) ATCC Patent Deposit Designation PTA-6831; f) ATCC Patent Deposit Designation PTA-6871; g) ATCC Patent Deposit Designation PTA-6872; h) ATCC Patent Deposit Designation PTA-6875; and i) ATCC Patent Deposit Designation PTA-6873, wherein the polypeptide consists of amino acid residues 27 to 164 of SEQ ID NO: 2, and wherein the inflammation is reduced.